Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Laschinsky

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|January 5, 2024
NET-Induced Carcinoid Heart Disease Affecting Both Tricuspid and Aortic Valves Due to Patent Foramen Ovale and Right/Left Shunt: A Multi-imaging Challenge to Nuclear MedicineChristina Laschinsky, Matthias Welsner, Amir A Mahabadi, et al.
Radiologie (Heidelberg, Germany)|September 16, 2022
[Oncological theranostics in nuclear medicine]Christina Laschinsky, Ken Herrmann, Wolfgang Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Tumor Dose-Response Relationship of [<sup>131</sup>I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [<sup>124</sup>I]MIBG PETAlexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid CarcinomaChristina Laschinsky, Sarah Theurer, Thomas Herold, et al.
Seminars in Nuclear Medicine|January 4, 2022
Clinical Use of PET/MR in Oncology: An UpdateRobert Seifert, David Kersting, Christoph Rischpler, et al.
The Lancet. Oncology|August 7, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trialKim M Pabst, Manuel M Weber, Christina Laschinsky, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|January 5, 2024
NET-Induced Carcinoid Heart Disease Affecting Both Tricuspid and Aortic Valves Due to Patent Foramen Ovale and Right/Left Shunt: A Multi-imaging Challenge to Nuclear MedicineChristina Laschinsky, Matthias Welsner, Amir A Mahabadi, et al.
Radiologie (Heidelberg, Germany)|September 16, 2022
[Oncological theranostics in nuclear medicine]Christina Laschinsky, Ken Herrmann, Wolfgang Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Tumor Dose-Response Relationship of [<sup>131</sup>I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [<sup>124</sup>I]MIBG PETAlexandros Moraitis, Andre Prochnow, Thorsten Dirk Poeppel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 26, 2023
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid CarcinomaChristina Laschinsky, Sarah Theurer, Thomas Herold, et al.
Seminars in Nuclear Medicine|January 4, 2022
Clinical Use of PET/MR in Oncology: An UpdateRobert Seifert, David Kersting, Christoph Rischpler, et al.
The Lancet. Oncology|August 7, 2025
[<sup>68</sup>Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trialKim M Pabst, Manuel M Weber, Christina Laschinsky, et al.
Pageof 1